Chimera botulinum toxin type E

Details for Australian Patent Application No. 2005205597 (hide)

Owner Allergan, Inc.

Inventors Steward, Lance E.; Aoki, Kei Roger; Fernandez-Salas, Ester; Herrington, Todd M.

Agent Davies Collison Cave

Pub. Number AU-A-2005205597

PCT Pub. Number WO2005/068494

Priority 10/757,077 14.01.04 US

Filing date 14 January 2005

Wipo publication date 28 July 2005

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/068494 Priority application(s): WO2005/068494

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205600-1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxy butane refrigerant compositions comprising a fluoroether and uses thereof

2005205596